-
Albumedix Completes Commercial-Scale Mfg. Facility Expansion
contractpharma
April 15, 2021
Albumedix Ltd. completed the expansion of its commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art labs at its UK-based campus in Nottingham.
-
Microbiologics Expands Virology Services
contractpharma
April 15, 2021
Microbiologics is investing in an additional 650-sq.-ft. Biosafety Level 3 (BSL-3) facility within its existing building at its global headquarters in St. Cloud, MN.
-
Rossari Biotech commissions greenfield manufacturing facility at Dahej, Gujarat
expresspharma
April 01, 2021
The greenfield facility will have a total installed capacity 132,500 MTPA, enhancing the total capacity of Rossari by 2.1x to 252,500 MTPA.
-
Northwest Biotherapeutics Adds Production Capacity at UK Facility
contractpharma
March 18, 2021
Dendritic cell vaccine production capacity for personalized immune therapies increases from about 4 - 6 patients per month to about 40 - 45 patients per month.
-
Arranta Bio Invests in New Manufacturing Facility
contractpharma
March 10, 2021
Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.
-
Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
contractpharma
March 08, 2021
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, held a virtual ground-breaking ceremony to celebrate the start of its large-scale cell culture expansion ...
-
Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
contractpharma
March 04, 2021
Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, broke ground on its new 25,000 square foot facility which will house its GMP virus ...
-
Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion
contractpharma
February 23, 2021
Avid Bioservices, Inc., a biologics CDMO, initiated the second phase of expansion of manufacturing capacity at its Myford facility.
-
Century Therapeutics Significantly Expands Capabilities
contractpharma
February 20, 2021
Century Therapeutics, a cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced a significant expansion of its operational and laboratory space in Philadelphia, as well as progress on its ...
-
Biopharma Manufacturer HPNE Continues Expansion
contractpharma
February 05, 2021
High Purity New England (HPNE), a biopharma solutions manufacturer and distributor, has acquired their third facility, expanding their total footprint to include more than 100,000 square feet under roof.